Appili Therapeutics Inc.
APLIF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,309 | $3,476 | $3,889 | $8,163 |
| - Cash | $1,228 | $94 | $6,665 | $11,063 |
| + Debt | $12,294 | $8,185 | $4,979 | $1,033 |
| Enterprise Value | $15,375 | $11,567 | $2,203 | -$1,867 |
| Revenue | $100 | $827 | $334 | $1,391 |
| % Growth | -87.9% | 147.6% | -76% | – |
| Gross Profit | $100 | $827 | $334 | $1,391 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $361 | -$2,067 | -$8,104 | -$23,512 |
| % Margin | 359% | -249.8% | -2,425.1% | -1,690.7% |
| Net Income | -$2,625 | -$3,781 | -$9,243 | -$25,118 |
| % Margin | -2,613.1% | -457% | -2,765.9% | -1,806.2% |
| EPS Diluted | -0.022 | -0.031 | -0.081 | -0.376 |
| % Growth | 30.8% | 61.6% | 78.4% | – |
| Operating Cash Flow | $869 | -$2,464 | -$19,081 | -$11,451 |
| Capital Expenditures | -$2 | -$30 | -$3 | -$8 |
| Free Cash Flow | $866 | -$2,494 | -$19,084 | -$11,459 |